NCT00005616View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 1999

Primary Completion Date

August 31, 2000

Study Completion Date

August 31, 2000

Conditions
Colorectal CancerMetastatic Cancer
Interventions
PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

PROCEDURE

radionuclide imaging

RADIATION

iodine I 131 monoclonal antibody F19

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00005616 - Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer | Biotech Hunter | Biotech Hunter